Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Fundamental Analysis

DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR

3.65  0 (0%)

Fundamental Rating

5

Overall UPR gets a fundamental rating of 5 out of 10. We evaluated UPR against 959 industry peers in the Health Care Providers & Services industry. UPR scores excellent on profitability, but there are concerns on its financial health. UPR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year UPR was profitable.
UPR had a positive operating cash flow in the past year.
In the past 5 years UPR has always been profitable.
In the past 5 years UPR always reported a positive cash flow from operatings.
UPR.I Yearly Net Income VS EBIT VS OCF VS FCFUPR.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of UPR (4.53%) is better than 81.48% of its industry peers.
UPR has a better Return On Equity (15.98%) than 85.19% of its industry peers.
UPR has a Return On Invested Capital of 9.18%. This is amongst the best in the industry. UPR outperforms 88.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UPR is below the industry average of 11.64%.
The last Return On Invested Capital (9.18%) for UPR is above the 3 year average (9.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROIC 9.18%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
UPR.I Yearly ROA, ROE, ROICUPR.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

UPR has a Profit Margin of 2.32%. This is comparable to the rest of the industry: UPR outperforms 51.85% of its industry peers.
In the last couple of years the Profit Margin of UPR has grown nicely.
UPR's Operating Margin of 3.06% is in line compared to the rest of the industry. UPR outperforms 40.74% of its industry peers.
UPR's Operating Margin has improved in the last couple of years.
The Gross Margin of UPR (15.43%) is worse than 70.37% of its industry peers.
UPR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
UPR.I Yearly Profit, Operating, Gross MarginsUPR.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

UPR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, UPR has about the same amount of shares outstanding.
UPR has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for UPR has been reduced compared to a year ago.
UPR.I Yearly Shares OutstandingUPR.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
UPR.I Yearly Total Debt VS Total AssetsUPR.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

UPR has an Altman-Z score of 2.84. This is not the best score and indicates that UPR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of UPR (2.84) is better than 77.78% of its industry peers.
UPR has a debt to FCF ratio of 18.31. This is a negative value and a sign of low solvency as UPR would need 18.31 years to pay back of all of its debts.
The Debt to FCF ratio of UPR (18.31) is worse than 77.78% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that UPR is somewhat dependend on debt financing.
UPR has a Debt to Equity ratio (0.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Altman-Z 2.84
ROIC/WACC1
WACC9.22%
UPR.I Yearly LT Debt VS Equity VS FCFUPR.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

UPR has a Current Ratio of 0.88. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
UPR has a Current ratio (0.88) which is comparable to the rest of the industry.
UPR has a Quick Ratio of 0.88. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of UPR (0.56) is worse than 70.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.56
UPR.I Yearly Current Assets VS Current LiabilitesUPR.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

UPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.33%, which is quite impressive.
The Earnings Per Share has been growing by 15.47% on average over the past years. This is quite good.
Looking at the last year, UPR shows a quite strong growth in Revenue. The Revenue has grown by 8.51% in the last year.
Measured over the past years, UPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%

3.2 Future

The Earnings Per Share is expected to grow by 19.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 2.31% on average over the next years.
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue Next Year4.99%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UPR.I Yearly Revenue VS EstimatesUPR.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
UPR.I Yearly EPS VS EstimatesUPR.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

UPR is valuated correctly with a Price/Earnings ratio of 15.21.
UPR's Price/Earnings ratio is a bit cheaper when compared to the industry. UPR is cheaper than 74.07% of the companies in the same industry.
UPR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.52, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.13, which indicates a correct valuation of UPR.
The rest of the industry has a similar Price/Forward Earnings ratio as UPR.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, UPR is valued a bit cheaper.
Industry RankSector Rank
PE 15.21
Fwd PE 16.13
UPR.I Price Earnings VS Forward Price EarningsUPR.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as UPR.
Based on the Price/Free Cash Flow ratio, UPR is valued expensively inside the industry as 81.48% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 42.72
EV/EBITDA 10.42
UPR.I Per share dataUPR.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of UPR may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)0.98
EPS Next 2Y8.96%
EPS Next 3Y9.35%

3

5. Dividend

5.1 Amount

UPR has a yearly dividend return of 0.87%, which is pretty low.
UPR's Dividend Yield is comparable with the industry average which is at 2.85.
Compared to an average S&P500 Dividend Yield of 2.38, UPR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

On average, the dividend of UPR grows each year by 33.58%, which is quite nice.
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
UPR.I Yearly Dividends per shareUPR.I Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

UPR pays out 7.91% of its income as dividend. This is a sustainable payout ratio.
UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.91%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
UPR.I Yearly Income VS Free CF VS DividendUPR.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
UPR.I Dividend Payout.UPR.I Dividend Payout, showing the Payout Ratio.UPR.I Dividend Payout.PayoutRetained Earnings

UNIPHAR PLC

DUB:UPR (6/6/2025, 7:00:00 PM)

3.65

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)09-01 2025-09-01
Inst Owners44.92%
Inst Owner ChangeN/A
Ins Owners5.43%
Ins Owner ChangeN/A
Market Cap947.43M
Analysts82
Price Target4.79 (31.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP7.91%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.96%
PT rev (3m)4.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE 15.21
Fwd PE 16.13
P/S 0.34
P/FCF 42.72
P/OCF 7.62
P/B 2.36
P/tB N/A
EV/EBITDA 10.42
EPS(TTM)0.24
EY6.58%
EPS(NY)0.23
Fwd EY6.2%
FCF(TTM)0.09
FCFY2.34%
OCF(TTM)0.48
OCFY13.12%
SpS10.67
BVpS1.55
TBVpS-0.64
PEG (NY)1.5
PEG (5Y)0.98
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROCE 10.78%
ROIC 9.18%
ROICexc 10.57%
ROICexgc 62.78%
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
FCFM 0.8%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
ROICexc(3y)10.45%
ROICexc(5y)10.56%
ROICexgc(3y)82.98%
ROICexgc(5y)N/A
ROCE(3y)10.62%
ROCE(5y)10.36%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.71%
ROICexc growth 5Y-1.65%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
F-Score6
Asset Turnover1.96
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Debt/EBITDA 3.12
Cap/Depr 288.68%
Cap/Sales 3.68%
Interest Coverage 2.89
Cash Conversion 103.55%
Profit Quality 34.55%
Current Ratio 0.88
Quick Ratio 0.56
Altman-Z 2.84
F-Score6
WACC9.22%
ROIC/WACC1
Cap/Depr(3y)149.63%
Cap/Depr(5y)116.24%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.5%
Profit Quality(3y)72.81%
Profit Quality(5y)95.5%
High Growth Momentum
Growth
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%
Revenue Next Year4.99%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.31%
EBIT growth 1Y9.42%
EBIT growth 3Y12.44%
EBIT growth 5Y16.03%
EBIT Next Year49.95%
EBIT Next 3Y20.25%
EBIT Next 5Y12.87%
FCF growth 1Y7.9%
FCF growth 3Y-16.24%
FCF growth 5Y-26.09%
OCF growth 1Y136.65%
OCF growth 3Y33.54%
OCF growth 5Y3.04%